Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.
CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although mainly second generation (2G) CARs carrying CD28 or 4-1BB have been investigated in patients, preclinical studies suggest that third generation (3G) CARs with both CD28 and 4-1BB have enhanced capaci...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144787&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849723614003200000 |
|---|---|
| author | Hannah Karlsson Emma Svensson Camilla Gigg Malin Jarvius Ulla Olsson-Strömberg Barbara Savoldo Gianpietro Dotti Angelica Loskog |
| author_facet | Hannah Karlsson Emma Svensson Camilla Gigg Malin Jarvius Ulla Olsson-Strömberg Barbara Savoldo Gianpietro Dotti Angelica Loskog |
| author_sort | Hannah Karlsson |
| collection | DOAJ |
| description | CD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although mainly second generation (2G) CARs carrying CD28 or 4-1BB have been investigated in patients, preclinical studies suggest that third generation (3G) CARs with both CD28 and 4-1BB have enhanced capacity. However, little is known about the intracellular signaling pathways downstream of CARs. In the present work, we have analyzed the signaling capacity post antigen stimulation in both 2G and 3G CARs. 3G CAR T cells expanded better than 2G CAR T cells upon repeated stimulation with IL-2 and autologous B cells. An antigen-driven accumulation of CAR+ cells was evident post antigen stimulation. The cytotoxicity of both 2G and 3G CAR T cells was maintained by repeated stimulation. The phosphorylation status of intracellular signaling proteins post antigen stimulation showed that 3G CAR T cells had a higher activation status than 2G. Several proteins involved in signaling downstream the TCR were activated, as were proteins involved in the cell cycle, cell adhesion and exocytosis. In conclusion, 3G CAR T cells had a higher degree of intracellular signaling activity than 2G CARs which may explain the increased proliferative capacity seen in 3G CAR T cells. The study also indicates that there may be other signaling pathways to consider when designing or evaluating new generations of CARs. |
| format | Article |
| id | doaj-art-23e186a8ec914e45b4c3f9cd70cc82b1 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-23e186a8ec914e45b4c3f9cd70cc82b12025-08-20T03:10:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014478710.1371/journal.pone.0144787Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors.Hannah KarlssonEmma SvenssonCamilla GiggMalin JarviusUlla Olsson-StrömbergBarbara SavoldoGianpietro DottiAngelica LoskogCD19-targeting CAR T cells have shown potency in clinical trials targeting B cell leukemia. Although mainly second generation (2G) CARs carrying CD28 or 4-1BB have been investigated in patients, preclinical studies suggest that third generation (3G) CARs with both CD28 and 4-1BB have enhanced capacity. However, little is known about the intracellular signaling pathways downstream of CARs. In the present work, we have analyzed the signaling capacity post antigen stimulation in both 2G and 3G CARs. 3G CAR T cells expanded better than 2G CAR T cells upon repeated stimulation with IL-2 and autologous B cells. An antigen-driven accumulation of CAR+ cells was evident post antigen stimulation. The cytotoxicity of both 2G and 3G CAR T cells was maintained by repeated stimulation. The phosphorylation status of intracellular signaling proteins post antigen stimulation showed that 3G CAR T cells had a higher activation status than 2G. Several proteins involved in signaling downstream the TCR were activated, as were proteins involved in the cell cycle, cell adhesion and exocytosis. In conclusion, 3G CAR T cells had a higher degree of intracellular signaling activity than 2G CARs which may explain the increased proliferative capacity seen in 3G CAR T cells. The study also indicates that there may be other signaling pathways to consider when designing or evaluating new generations of CARs.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144787&type=printable |
| spellingShingle | Hannah Karlsson Emma Svensson Camilla Gigg Malin Jarvius Ulla Olsson-Strömberg Barbara Savoldo Gianpietro Dotti Angelica Loskog Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. PLoS ONE |
| title | Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. |
| title_full | Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. |
| title_fullStr | Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. |
| title_full_unstemmed | Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. |
| title_short | Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors. |
| title_sort | evaluation of intracellular signaling downstream chimeric antigen receptors |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144787&type=printable |
| work_keys_str_mv | AT hannahkarlsson evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT emmasvensson evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT camillagigg evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT malinjarvius evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT ullaolssonstromberg evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT barbarasavoldo evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT gianpietrodotti evaluationofintracellularsignalingdownstreamchimericantigenreceptors AT angelicaloskog evaluationofintracellularsignalingdownstreamchimericantigenreceptors |